Freiburg Im Breisgau

Germany

485 total trials 203 recruiting

Filter these 485 trials by phase, condition, sponsor and more.

Open in Search →

CheckMate 901: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 901 Ended

2022-501784-40-00 5 2017-05-26 Untreated Unresectable or Metastatic Urothelial Cancer
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of … Ended

2024-512934-14-00 5 2016-11-07 advanced or metastatic adenocarcinoma of the stomach or gastroesophage
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended

2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma
Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1) Ended

2023-510361-97-00 5 Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodys

Showing 481–485 of 485 trials